We demonstrate that KIF20A is significantly overexpressed in NSCLC tissues and correlates with poor prognosis, primary resistance to anti-PD-1 therapy, and suppressed PD-L1 expression. Here, KIF20A is linked to non-small cell lung carcinoma.